(Q82569111)

English

Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia

scientific article published on 01 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

Christian Thiede

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Martin Bornhäuser

14

object named as

Bornhäuser M

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Uwe Platzbecker

1

object named as

Platzbecker U

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Gerhard Ehninger

13

object named as

Ehninger G

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Füssel M

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Geissler G

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Illmer T

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Mohr B

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Hänel M

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Mahlberg R

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Krümpelmann U

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Weissinger F

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Schaich M

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Theuser C

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

707-714

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16482208%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404143

0 references

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of allogeneic transplantation in high-risk acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-parametric inference for cumulative incidence functions in competing risks studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

The use and potential of bone marrow allograft and whole-body irradiation in the treatment of leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors in Older Patients With Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation from unrelated donors as an effective therapy for older patients (> or = 60 years) with active myeloid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404143

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82569111&oldid=1985165495"